Chondroitin

INT-767 is a dual farnesoid X receptor (FXR)/TGR5 agonist with mean EC 50 s of 30 and 630 nM, respectively.In VitroINT-767 does not show cytotoxic effects in HepG2 cells, does not inhibit cytochrome P450 enzymes, is highly stable to phase I and II

INT-767 is a dual farnesoid X receptor (FXR)/TGR5 agonist with mean EC 50 s of 30 and 630 nM, respectively.In VitroINT-767 does not show cytotoxic effects in HepG2 cells, does not inhibit cytochrome P450 enzymes, is highly stable to phase I and II

InformationLiproxstatin-1 Liproxstatin-1 is a potent ferroptosis inhibitor with an IC50 of 22 nM.In vitroLiproxstatin-1 is able to inhibit ferroptosis in the low nanomolar range and inhibit the growth of Gpx4−/−cells with IC50 of 22 nM.

InformationLiproxstatin-1 Liproxstatin-1 is a potent ferroptosis inhibitor with an IC50 of 22 nM.Targetsferroptosis (Cell-free assay) 22 nMIn vitroLiproxstatin-1 is able to inhibit ferroptosis in the low nanomolar range and inhibit the growth of

InformationLiproxstatin-1 Liproxstatin-1 is a potent ferroptosis inhibitor with an IC50 of 22 nM.Targetsferroptosis (Cell-free assay) 22 nMIn vitroLiproxstatin-1 is able to inhibit ferroptosis in the low nanomolar range and inhibit the growth of

InformationLiproxstatin-1 Liproxstatin-1 is a potent ferroptosis inhibitor with an IC50 of 22 nM.Targetsferroptosis (Cell-free assay) 22 nMIn vitroLiproxstatin-1 is able to inhibit ferroptosis in the low nanomolar range and inhibit the growth of

InformationLiproxstatin-1 Liproxstatin-1 is a potent ferroptosis inhibitor with an IC50 of 22 nM.Targetsferroptosis (Cell-free assay) 22 nMIn vitroLiproxstatin-1 is able to inhibit ferroptosis in the low nanomolar range and inhibit the growth of

InformationLiproxstatin-1 Liproxstatin-1 is a potent ferroptosis inhibitor with an IC50 of 22 nM.Targetsferroptosis (Cell-free assay) 22 nMIn vitroLiproxstatin-1 is able to inhibit ferroptosis in the low nanomolar range and inhibit the growth of

Application MB-3 has been used as a general control non-repressible 5 (GCN5) inhibitor: to study its effects on lamin A/C-associated pY19-Cav-2-mediated histone H3 acetylations to analyze its effects on the growth of Arabidopsis thaliana

Application MB-3 has been used as a general control non-repressible 5 (GCN5) inhibitor: to study its effects on lamin A/C-associated pY19-Cav-2-mediated histone H3 acetylations to analyze its effects on the growth of Arabidopsis thaliana

General description Nanodisc technology is an approach to render membrane proteins soluble in aqueous solutions in a native-like bilayer environment, where the membrane proteins remain stable and active. The Nanodisc concept is derived from high

MK2-IN-1 hydrochloride is a potent and selecitve MAPKAPK2(MK2) inhibitor(IC50=0.11 uM) with a non-ATP competitive binding mode.IC50 value: 0.11 uM Target: MAPKAPK2(MK2) inhibitorMK2-IN-1 was profiled for kinase selectivity by screening against a